Novo Nordisk supports new Guiding Principles on Access to Healthcare

Primary tabs

Novo Nordisk supports new Guiding Principles on Access to Healthcare

13 healthcare company CEOs make call to action to expand access to medicines and vaccines.
tweet me:
Novo Nordisk joins in support of new Guiding Principles on #Access to #Healthcare: #diabetes #CGI2013 @BSRnews
Thursday, September 26, 2013 - 9:00am

CONTENT: Press Release

September 26, 2013 /3BL Media/ – On 24 September, Business for Social Responsibility (BSR), together with CEOs from 13 pharmaceutical companies, released a new set of Guiding Principles on Access to Healthcare (GPAH). The principles are an industry-led call for more cross-sector collaboration to expand access to quality healthcare. The initiative supports the post-2015 development agenda through this common framework to shape viable global health goals. The GPAH were launched in conjunction with the United Nations General Assembly meetings taking place in New York City.

Novo Nordisk has been involved in developing the GPAH through the company’s participation in the BSR Healthcare Working Group and will contribute with best practices of how the principles can be put into action.

“We commend the commitment and effort of BSR to bring the pharmaceutical industry together to create a joint framework on access to healthcare,” says Charlotte Ersbøll, corporate vice president, Global Stakeholder Engagement, Novo Nordisk. “Improvement is needed to ensure access to healthcare for all and cross-sector collaboration is an obvious answer to make sure this happens.”

BSR’s Healthcare Working Group developed the principles, which build on the experience and lessons learned from cross-sector partnerships that help improve access to medicines and vaccines for areas as diverse as HIV/AIDS, diabetes, neglected tropical diseases, and childhood immunization.

Novo Nordisk has contributed three company case studies to help make the GPAH tangible and to support sharing of best practices. The company’s case studies include the Base of the Pyramid Innovation Project, Differential Pricing Policy for Least Developed Countries and the Changing Diabetes® in Children programme.

Novo Nordisk’s case studies can be found at


About BSR

BSR works with its global network of more than 250 member companies to build a just and sustainable world. From its offices in Asia, Europe, and North and South America, BSR develops sustainable business strategies and solutions through consulting, research, and cross-sector collaboration. Visit for more information about BSR’s more than 20 years of leadership in sustainability.

About Novo Nordisk

Headquartered in Denmark, Novo Nordisk is a global healthcare company with 90 years of innovation and leadership in diabetes care. The company strives to conduct its activities in a financially, environmentally and socially responsible way through its Triple Bottom Line business principle. The strategic commitment to corporate sustainability has brought the company onto centre stage as a leading player in today’s business environment, recognised for its integrated reporting, stakeholder engagement and consistently high sustainability performance.

Explore Novo Nordisk’s approach to sustainability.

Keywords: Health | Collaboration/Partnerships | Health | Novo Nordisk | Volunteerism & Community Engagement | access to medicine | diabetes | sustainability

CONTENT: Press Release